Eledon Pharmaceuticals (ELDN) Non-cash Items (2013 - 2014)
Eledon Pharmaceuticals posted quarterly Non-cash Items of $19.8 million for Q4 2014, up 744.08% year-on-year from $2.3 million in Q4 2013, and up 744.08% on a QoQ basis from $2.3 million in Q4 2013.
Eledon Pharmaceuticals (ELDN) has 2 years of Non-cash Items data on file, last reported at $19.8 million in Q4 2014.
- For the quarter ending Q4 2014, Non-cash Items rose 744.08% year-over-year to $19.8 million; the trailing twelve-month figure through Dec 2014 stood at $19.8 million (up 744.08% YoY), and the FY2014 full-year result was $19.8 million, up 744.08% from the prior year.
- Non-cash Items for Q4 2014 stood at $19.8 million, up from $2.3 million in the prior quarter.
- Across five years, Non-cash Items topped out at $19.8 million in Q4 2014 and bottomed at $2.3 million in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 19.80 Mn |
| Dec 31, 2014 | 19.80 Mn |
| Dec 31, 2013 | 2.35 Mn |
| Dec 31, 2013 | 2.35 Mn |